I am currently developing a new approach in conducting sensory examinations via the Olfactory Response Baseline Identification Test (O.R.B.I.T) in conjunction with MGH and the Aging Brain Initiative. Based upon prior research (1), findings reveal olfactory testing to be an early detector of Alzheimer’s and Dementia (2), even aiding in differentiating the conditions based on identification distance per nostril . Furthermore, (according to HMS) "temporary loss of smell, or anosmia, is the main neurological symptom and one of the earliest and most commonly reported indicators of COVID-19.” In spite of the fact that these scientific principals are well founded, no mechanized or automated tools have been created to collect olfactory data for these medical purposes prior to the ORBIT. Therefore, the current prototype is under evaluation with key stakeholders on the ICU frontlines at MGH, Spaulding and within the Alzheimer’s testing domain as part of the Aging Brain Initiative.
This sensory test device automates a crucial portion of the MCPT (Multisensory Cognition Proficiency Test). The O.R.B.I.T. will be the first of many mechanical designs supporting research in detecting and tracking sensory indicators of neurological performance and health throughout GAMMA treatment.